234 related articles for article (PubMed ID: 28552539)
1. Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinoma.
Foroozan M; Roudi R; Abolhasani M; Gheytanchi E; Mehrazma M
Pathol Res Pract; 2017 Jun; 213(6):612-618. PubMed ID: 28552539
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
3. Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ.
Hou H; Chen W; Zhao L; Zuo Q; Zhang G; Zhang X; Wang H; Gong H; Li X; Wang M; Wang Y; Li X
J Clin Pathol; 2012 Dec; 65(12):1088-96. PubMed ID: 22944623
[TBL] [Abstract][Full Text] [Related]
4. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
[TBL] [Abstract][Full Text] [Related]
5. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
Kimura T; Furusato B; Miki J; Yamamoto T; Hayashi N; Takahashi H; Kamata Y; van Leenders GJ; Visakorpi T; Egawa S
Pathol Int; 2012 Nov; 62(11):742-8. PubMed ID: 23121605
[TBL] [Abstract][Full Text] [Related]
6. Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
Hoogland AM; Verhoef EI; Roobol MJ; Schröder FH; Wildhagen MF; van der Kwast TH; Jenster G; van Leenders GJ
Prostate; 2014 May; 74(5):488-96. PubMed ID: 24375374
[TBL] [Abstract][Full Text] [Related]
7. CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance.
Harris KS; Shi L; Foster BM; Mobley ME; Elliott PL; Song CJ; Watabe K; Langefeld CD; Kerr BA
Sci Rep; 2021 Jan; 11(1):1465. PubMed ID: 33446896
[TBL] [Abstract][Full Text] [Related]
8. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.
Kalantari E; Saadi FH; Asgari M; Shariftabrizi A; Roudi R; Madjd Z
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):592-598. PubMed ID: 26894647
[TBL] [Abstract][Full Text] [Related]
10. IgG gene expression and its possible significance in prostate cancers.
Liu Y; Chen Z; Niu N; Chang Q; Deng R; Korteweg C; Gu J
Prostate; 2012 May; 72(6):690-701. PubMed ID: 22430367
[TBL] [Abstract][Full Text] [Related]
11. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
Zhang L; Guo F; Gao X; Wu Y
Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
[TBL] [Abstract][Full Text] [Related]
12. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
13. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma.
Ghods R; Ghahremani MH; Madjd Z; Asgari M; Abolhasani M; Tavasoli S; Mahmoudi AR; Darzi M; Pasalar P; Jeddi-Tehrani M; Zarnani AH
Cancer Immunol Immunother; 2014 Dec; 63(12):1319-27. PubMed ID: 25186610
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
15. Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Yılmaz Akçay E; Tepeoğlu M; Börcek P; Dirim A
Ann Diagn Pathol; 2020 Apr; 45():151480. PubMed ID: 32106037
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma.
Park JY; Yoon G
Pathol Oncol Res; 2017 Jan; 23(1):189-196. PubMed ID: 27817002
[TBL] [Abstract][Full Text] [Related]
17. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
[TBL] [Abstract][Full Text] [Related]
18. Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
Mortezavi A; Salemi S; Rupp NJ; Rüschoff JH; Hermanns T; Poyet C; Randazzo M; Simon HU; Moch H; Sulser T; Wild P; Eberli D
Oncotarget; 2017 May; 8(19):31765-31774. PubMed ID: 28423666
[TBL] [Abstract][Full Text] [Related]
19. Loss of PLZF expression in prostate cancer by immunohistochemistry correlates with tumor aggressiveness and metastasis.
Xiao GQ; Unger P; Yang Q; Kinoshita Y; Singh K; McMahon L; Nastiuk K; Sha K; Krolewski J; Burstein D
PLoS One; 2015; 10(3):e0121318. PubMed ID: 25807461
[TBL] [Abstract][Full Text] [Related]
20. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
